vialroom

#cagrilintide 2026-03-09

Monday32 messages6 participantstimes are UTC
Highlights from this day
  • blind_submit — anyone stopped the GLP-1 and kept only this i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something 21:13
  • blind_submit — is 2.4 the number for this too or am i confusing compounds 21:32
  • amylin_amy — did the nausea feel different to you or just less 21:47
  • relabel_watch — back after 5 months, is monotherapy still a minority thing here 21:51
MC

i titrated over twice as many weeks as i did on semaglutide and that was right for me

went slower because the first step gave me two rough days and i took that as information

AA

combination GI was worse than either alone for me, which is not what i had read anywhere

i was sceptical about monotherapy and after 11 months im still sceptical, just less so

lost 69lb over 15 months on the combination and i genuinely cannot apportion it

AA

how do people separate which of the two is doing what in a combination

BS

anyone stopped the GLP-1 and kept only this
i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something

🤝18👍14

amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

[edited]
📈4🧪2

changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing

👍4

different not less

combination for me

AA

update on the earlier thing REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work

🧊1
AA

monotherapy was underwhelming for me and i say that as someone who wanted it to work

did the nausea feel different to you or just less

🙏1😂8🤝17

follow up CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

is the combination just the two dosed together or a single formulation

back after 5 months, is monotherapy still a minority thing here

⚠️16📉2❤️2

anyone got two Medutest results on the same QSC lot for this

MC

is the weekly schedule the same here

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.

monotherapy did work for me, just slower and smaller than i expected